Clinical outcome (CO) and predictive factors (PRE) evaluation of young (≤ 60 years) castration-resistant prostate cancer (CRPC) patients, treated with docetaxel (DOC): Preliminary results of an Italian multicenter retrospective study (CYCLOP study).
Orazio Caffo
No relevant relationships to disclose
Cinzia Ortega
No relevant relationships to disclose
Giuseppe Di Lorenzo
No relevant relationships to disclose
Francesca La Russa
No relevant relationships to disclose
Salvatore Luca Burgio
No relevant relationships to disclose
Caterina Messina
No relevant relationships to disclose
Gaetano Facchini
No relevant relationships to disclose
Roberto Iacovelli
No relevant relationships to disclose
Michele Lodde
No relevant relationships to disclose
Franco Morelli
No relevant relationships to disclose
Francesco Massari
No relevant relationships to disclose
Giuseppe Procopio
No relevant relationships to disclose
Fable Zustovich
No relevant relationships to disclose
Giovanni Lo Re
No relevant relationships to disclose
Cristina Pegoraro
No relevant relationships to disclose
Teresa Gamucci
No relevant relationships to disclose
Giovanni L. Pappagallo
No relevant relationships to disclose
Antonello Veccia
No relevant relationships to disclose
Francesca Maines
No relevant relationships to disclose
Enzo Galligioni
No relevant relationships to disclose